You are here : Home > Serum miR-483-5p and miR-195 are predictive of recurrence risk in adrenocortical cancer patients

publications-2011-2013

Serum miR-483-5p and miR-195 are predictive of recurrence risk in adrenocortical cancer patients

Published on 19 March 2015
Serum miR-483-5p and miR-195 are predictive of recurrence risk in adrenocortical cancer patients
Authors
Chabre O, Libe R, Assie G, Barreau O, Bertherat J, Bertagna X, Feige JJ, Cherradi N
Journal
Year2013
InstituteiRTSV

Go back to list